Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18895888 | 0.85 | — | — | |
| SCHEMBL10311038 | 0.80 | CDC7 (0.45) | PIK3CG | |
| SCHEMBL23367909 | 0.78 | SMN1; SMN2 (0.47) | — | |
| SCHEMBL7229326 | 0.78 | HDAC1 (0.31) | — | |
| SCHEMBL1774876 | 0.77 | PDPK1 (0.32) | PDPK1 | |
| SCHEMBL5121295 | 0.77 | HCAR2 (0.40) | PDPK1 | |
| SCHEMBL1754099 | 0.77 | SLC6A3 (0.36) | PDPK1 | |
| SCHEMBL1207028 | 0.77 | ALDH1A1 (0.44) | — | |
| SCHEMBL17773144 | 0.75 | KDM4E (0.45) | — | |
| SCHEMBL21654019 | 0.75 | KDM4E (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3400253-B1 | DITHIOPHENETHIADIAZOLE SEMICONDUCTORS AND RELATED DEVICES | FLEXTERRA INC (US) | 2023-10-04 | — | — | EP | disclosed |
| US-20170233384-A1 | Thienothiadiazole Compounds and Related Semiconductor Devices | USINVEST LLC | 2017-08-17 | — | — | US | disclosed |
| WO-2017120572-A1 | DITHIOPHENETHIADIAZOLE SEMICONDUCTORS AND RELATED DEVICES | FLEXTERRA, INC. (US) | 2017-07-13 | — | — | WO | disclosed |
| US-RE44304-E1 | Conjugated monomers and polymers and preparation and use thereof | NORTHWESTERN UNIVERSITY (US) | 2013-06-18 | — | — | US | disclosed |
| US-7928249-B2 | Conjugated monomers and polymers and preparation and use thereof | NORTHWESTERN UNIVERSITY (US) | 2011-04-19 | — | — | US | disclosed |
| US-20090036643-A1 | Conjugated monomers and polymers and preparation and use thereof | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233384-A1 | Thienothiadiazole Compounds and Related Semiconductor Devices | TST, SLC19A2, TPST2 | PDPK1 2634/4885CDK2 228/4885PIK3CG 2638/4885 |
| US-20090036643-A1 | Conjugated monomers and polymers and preparation and use thereof | PCNA, HMGB1, HMGB3 | PDPK1 4256/4885CDK2 1825/4885PIK3CG 2740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.